Key result
Endovascular aneurysm repair and open repair demonstrated similar 30-day mortality rates for ruptured abdominal aortic aneurysms, though overall evidence slightly favors endovascular repair due to potential mid-term survival benefits and cost-effectiveness.
Why the study?
Management modalities of ruptured abdominal aortic aneurysm include open repair and endovascular repair, prompting a systematic review of randomized controlled trials comparing both approaches.
Does ruptured endovascular aneurysm repair (rEVAR) improve mortality and clinical outcomes compared to ruptured open aneurysm repair (rOAR) in patients with ruptured abdominal aortic aneurysm?
Systematic Review (n=868)
Does ruptured endovascular aneurysm repair (rEVAR) improve mortality and clinical outcomes compared to ruptured open aneurysm repair (rOAR) in patients with ruptured abdominal aortic aneurysm?
While short-term mortality is similar between EVAR and OAR for ruptured abdominal aortic aneurysms, EVAR may offer mid-term survival benefits, shorter hospital stays, and improved quality of life.
Similar 30-day mortality supports individualized rEVAR or rOAR selection; extends evidence for potential mid-term EVAR benefits in ruptured AAA.
Management modalities of ruptured abdominal aortic aneurysm (AAA) include ruptured open aneurysm repair (rOAR) and ruptured endovascular aneurysm repair (rEVAR). In this study, we aim to systematically review all the previously published randomized controlled trials (RCTs) that compared rOAR and rEVAR. A systematic search was performed in the following databases: PubMed, Scopus, Web of Science, Google Scholar, Clinical trials, and others with all the potentially relevant keywords that were adjusted to meet the search strategy for each database to collect all the relevant studies that were published up to January 2021. A total of 11 studies were identified through our comprehensive search. Among these studies, seven represented the IMPROVE trial, two represented the AJAX trial, and two represented the Nottingham and ECAR trials, each, while the remaining four studies were not RCTs; however, these were included in the discussion as they obtained data from the IMPROVE trial. The IMPROVE trials preferred EVAR use due to the potential survival benefit and improved quality of life, although the EVAR and OAR had similar mortality rates. In the AJAX and ECAR, the mortality rates favored EVAR over OAR with no significance while the opposite was noticed in the Nottingham trial with no significance also. Similar rates of re-interventions and complications were also noticed and some studies reported that EVAR is cost-effective. Overall evidence slightly favors EVAR over OAR and further studies are needed.
No takes yet. Share an insight, caveat, or question.
Alnefaie et al. (2022) conducted a systematic review in Ruptured abdominal aortic aneurysm (n=868). Endovascular aneurysm repair (EVAR) vs. Open aneurysm repair (OAR) was evaluated on All-cause mortality. Endovascular aneurysm repair and open repair demonstrated similar 30-day mortality rates for ruptured abdominal aortic aneurysms, though overall evidence slightly favors endovascular repair due to potential mid-term survival benefits and cost-effectiveness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: